Search
Now showing items 1-1 of 1
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance.
(2018-06)
BACKGROUND: A combined clinical cell-cycle risk (CCR) score that incorporates prognostic molecular and clinical information has been recently developed and validated to improve prostate cancer mortality (PCM) risk ...